The Inventor’s Patent Academy Updates
Invent Together and Qualcomm Inc recently updated TIPA to enhance the course content as well as increase its functionality and accessibility. TIPA is now accessible via mobile, has voice narration, shortened learning capsules and extra resource links. Currently around 1200 students are enrolled in the program and USPTO’s First-Time Filer Expedited Examination Pilot Program is using TIPA as a learning resource. This is a brilliant resource, and we hope TIPA can keep expanding to create further innovation and patenting opportunities for underrepresented groups.
Click here to read more
Global Health – New EU Strategy
A new EU Global Health Strategy (GHS) to be developed this year has been developed to ensure that the EU remains an effective and progressive global health player, delivering on its Sustainable Development Goals (SDGs) and continuing its commitment to promote healthy lives and well-being for all.
There are various opportunities to contribute to EU law-making as it evolves – from the preparation phase through to proposals for new laws and evaluations of how existing EU laws are performing. The Commission has invited stakeholders to share their views and ideas about the Global Health Strategy on the Have Your Say portal.
You can learn more by watching the Global Health Policy Forum which allowed for interventions from stakeholders on how to develop the EU Global Health Strategy, or you can click here for more information.
Online Seminar on the Intellectual Property Gender Gap in the European Region
Inclusive innovation ecosystems are a priority for Innovation Council. It is for this reason that we have collaborated with WIPO and Invent Together on preparing these high-level policy panels that will take place on May 31 and June 1.
The event will focus on the importance of designing policies addressing the IP gender gap and engaging women’s participation in the innovation ecosystems of the European region.
Click here for online registration.
New ECA Publication to Spotlight Breakthroughs of African Female Scientists
A new publication ‘Earth, Oceans and Skies: Insights from selected, outstanding African women scientists’ by the United Nations Economic Commission for Africa (ECA) will spotlight African female scientists whose contributions seek to address some of the most critical challenges of the UN’s Decade of Action leading up to the year 2030.
From exploring the depths of the ocean to studying the vastness of space, the publication features dozens of autobiographies of selected scientists including female doctors, engineers and scientists from Africa whose research and discoveries are helping to tackle complex global challenges.
Click here to read more.
IFPMA event on March 8th – Women Innovators in Africa
The virtual event, titled “Women-led innovation in Africa: Achieving sustainable health and gender equality on the continent” will take place in March to mark International Women’s Day. The event will demystify the notion that women have a limited role in innovation, celebrating the contribution made by women leaders, innovators, and creators to the development of societies and economies. The underpinning argument is that, without the considerable and equal participation of women in policymaking, business and innovation, it will be impossible to achieve the SDGs by 2030.
Join IFPMA, Speak Up Africa, and African women driving innovation and making advancements to achieve the SDGs on Tuesday, 08 March from 09:00-11:00 GMT / 10:00-12:00 CET. The panel will be part of Speak Up Africa’s broader African LeadHERs Forum. This virtual, two-hour moderated panel discussion will be held on Zoom, and interpretation from English to French will be available.
Slideshow: Extending Bio-manufacturing Networks in Africa and IP and Covid
This slideshow presents key messages from the recent Innovation Council – Bobab online discussion about extending bio-manufacturing networks in emerging regions, notably Africa. The discussion on February 8th featured Prof. Mark Schultz of the University of Akron School of Law, Anissa Boumlic of Merck Life Science, and Simon Agwale of the African Vaccine Manufacturing Initiative. Click here for the video of the event, and click here to review a transcript of the event.
Invent Together advocacy in favor of the IDEA Act
Invent Together is a coalition of organizations, universities, companies, and other stakeholders dedicated to understanding the diversity gaps in invention and patenting. It aims to support public policy and private initiatives working to close the diversity gap. They have been supporting the adoption of the Inventor Diversity for Economic Advancement (IDEA) Act, which would require the USPTO to collect data on inventors’ demographic data on a voluntary basis and make this information available in the aggregate for research.
The IDEA Act has recently passed the House as part of the America COMPETES Act. As the House and Senate negotiate a compromise, Invent Together is calling for Congress to keep the IDEA Act in the final version sent to President Biden’s office.
Invent Together has written a sign-on letter urging congressional leadership to keep the IDEA Act in the final innovation and competition bill which can be found here.
Bobab discussion about bio-manufacturing in emerging regions
The Innovation Council and Bobab organised a discussion on expanding BioManufacturing production capacity in emerging regions. Biologics, a category of pharmaceuticals which includes products such as vaccines and monoclonal antibody treatments, are quickly becoming among the most important medical products in the world. By combining enabling government policies and technology transfer between innovators and their global partners, it will be possible to improve availability of biologics, increase health security, and enhance scientific and industrial capacity in developing countries.
Click here to see the transcript.
Here’s why developing countries can make COVID-19 mRNA vaccines
Across the developing world, hundreds of millions of people are unable to get a vaccine to protect themselves from the ravages of COVID-19, and millions of them have already become infected and died. According to public health experts, relying on wealthy nations to donate billions of doses is not working. The solution many now believe is for the countries to do something that the big U.S. mRNA vaccine makers say is not feasible: manufacture the gold-standard mRNA shots themselves.